Atoma

Atoma Therapeutics is a Montreal-based biotechnology company focused on the discovery and development of novel therapies for chronic inflammatory and fibrotic diseases. The company's research centers on the concept of "inflammaging," targeting the underlying biological processes that drive age-related chronic inflammation. Founded by experienced industry veterans from Clementia Pharmaceuticals, Atoma leverages its proprietary insights to identify and develop small molecule candidates that can modulate key inflammatory pathways. The company's research is supported by AmorChem and is based on discoveries made at the University of Montreal.